MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
382 M |
Market Cap[1] |
$ 147 B |
EBITDA (LTM) |
$ 5.7 B |
P/E (LTM) |
45.39 |
P/S (LTM) |
6.26 |
EPS (LTM) |
8.46 |
Stryker Corporation is an international company specializing in the production of medical equipment and instruments for surgery. The company was founded in 1941 in the United States and has since become one of the leaders in its field.
Stryker Corporation offers a wide range of products, including implants for orthopedics, neurosurgery, traumatology, and other areas of medicine, as well as tools for surgical operations and rehabilitation equipment.
The company is actively developing and expanding its business around the world. Today, SYK has offices in more than 100 countries and holds leading positions in the medical equipment market.
One of the company's main goals is to create innovative products that will help improve the quality of life for patients and facilitate the work of medical professionals. Stryker Corporation also actively works on improving its technologies and processes to ensure high-quality products and maximum safety for patients.
Stryker Corporation is an example of a successful business that combines innovation, quality, and responsibility to patients.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Viemed Healthcare
VMD
|
$ 9.06 | 1.23 % | $ 347 M | Nasdaq Global Select Market | USA |
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
Bruker Corporation
BRKR
|
$ 38.78 | -1.25 % | $ 5.78 K | Nasdaq Global Select Market,SPB | USA |
 |
Cognyte Software Ltd.
CGNT
|
$ 8.15 | 4.22 % | $ 585 M | Nasdaq Global Select Market,SPB |  Israel |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
AdaptHealth Corp.
AHCO
|
$ 9.69 | 3.09 % | $ 1.31 B | Nasdaq Capital Market | USA |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 4.15 | 4.01 % | $ 155 M | Nasdaq Global Market |  France |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
CONMED Corporation
CNMD
|
$ 43.13 | -0.43 % | $ 1.34 B | NYSE,SPB | USA |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 29.17 | -2.21 % | $ 1.34 B | Nasdaq Capital Market,SPB | USA |
 |
Apyx Medical Corporation
APYX
|
$ 3.31 | 4.42 % | $ 115 M | Nasdaq Global Select Market | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Electromed
ELMD
|
$ 24.26 | 1.17 % | $ 205 M | NYSE American | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | Israel |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
Accuray Incorporated
ARAY
|
$ 0.53 | 0.68 % | $ 54.5 M | Nasdaq Global Select Market | USA |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
FONAR Corporation
FONR
|
$ 18.51 | 0.05 % | $ 121 M | Nasdaq Capital Market | USA |
 |
Cytosorbents Corporation
CTSO
|
$ 0.79 | -1.24 % | $ 43 M | Nasdaq Capital Market | USA |
 |
Align Technology
ALGN
|
$ 183.14 | 0.27 % | $ 13.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
Butterfly Network
BFLY
|
$ 3.99 | 7.7 % | $ 845 M | NYSE | USA |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
Abbott Laboratories
ABT
|
$ 113.59 | 0.01 % | $ 198 B | NYSE,SPB | USA |
 |
InMode Ltd.
INMD
|
$ 13.58 | -0.18 % | $ 878 M | Nasdaq Global Select Market,SPB | Israel |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
Boston Scientific Corporation
BSX
|
$ 72.75 | -1.49 % | $ 108 B | NYSE,SPB | USA |
 |
IRadimed Corporation
IRMD
|
$ 105.22 | 0.89 % | $ 1.33 B | Nasdaq Global Select Market | USA |
 |
IRIDEX Corporation
IRIX
|
$ 1.42 | -0.7 % | $ 22.9 M | Nasdaq Global Select Market | USA |
 |
Helius Medical Technologies
HSDT
|
$ 2.31 | 16.67 % | $ 1.4 M | Nasdaq Capital Market | USA |
 |
Alphatec Holdings
ATEC
|
$ 13.05 | 0.23 % | $ 1.96 B | Nasdaq Global Select Market | USA |
 |
Pulmonx Corporation
LUNG
|
$ 1.46 | -4.58 % | $ 57.1 M | Nasdaq Global Select Market | USA |
 |
Medigus Ltd.
MDGS
|
- | 10.28 % | $ 55.5 M | Nasdaq Global Select Market | Israel |
 |
Medtronic PLC
MDT
|
$ 95.96 | -0.8 % | $ 123 B | NYSE,SPB | USA |
 |
Edwards Lifesciences Corporation
EW
|
$ 85.73 | 0.55 % | $ 50.1 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.